Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Share-based Compensation (Details Textual)

v3.19.3.a.u2
Note 10 - Share-based Compensation (Details Textual) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross     700,000 900,000
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price     $ 190.73 $ 174.10
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 37.00 $ 34.69
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period   24,000 287,595 189,627
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value     $ 35.3 $ 16.3
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total $ 38.2   $ 38.2  
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition     2 years 1 month 6 days  
Selling, General and Administrative Expenses [Member]        
Share-based Payment Arrangement, Expense 10.1 $ 6.9 $ 18.5 $ 18.4
Cost of Sales [Member]        
Share-based Payment Arrangement, Expense $ 0.5   $ 0.9  
Restricted Stock Units (RSUs) [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     30,858 53,903
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 192.08 $ 170.74
Restricted Stock [Member]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     15,398 14,887
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value     $ 193.48 $ 125.05